IMU-838
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for IMU-838, covering 2021-07-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis [Phase 3]